About this trial
This study conducted a Post-Market Clinical Follow-Up study (PMCF) to evaluate the safety and effectiveness of the disposable endoscopic linear cutter stapler produced by Changzhou Ankang Medical Instrument Co., Ltd., through a retrospective analysis of the clinical data, to evaluate the safety and effectiveness of soft tissue resection, transection and anastomosis.
Eligibility criteria
Qualifiers
Age unlimited and gender unlimited;
The surgery type shall be endoscopic surgery;
The departments of surgical procedures: general and thoracic surgical procedures;
Investigational devices of all the models of the staplers and its cartridge listed in Section 2.3.
Disqualifiers
Patients undergoing surgery for contraindications to the product, such as severe mucosal edema, non-observation of hemostatic sites for surgery or off-label use, such as liver and spleen;
Combined with other similar products (stapler) for resection, transection and anastomosis of the surgical site;
Surgery record is incomplete, unable to extract main indicators related information.
Trial design
Treatments tested in this trial
- Disposable endoscopic linear cutter stapler
Treatment groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.